Lv, F.; Jiang, Y.; Wang, Y.; Zhang, T.; Zhou, Y.
AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis. J. Cardiovasc. Dev. Dis. 2022, 9, 406.
https://doi.org/10.3390/jcdd9110406
AMA Style
Lv F, Jiang Y, Wang Y, Zhang T, Zhou Y.
AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis. Journal of Cardiovascular Development and Disease. 2022; 9(11):406.
https://doi.org/10.3390/jcdd9110406
Chicago/Turabian Style
Lv, Feng, Yufeng Jiang, Yebao Wang, Ting Zhang, and Yafeng Zhou.
2022. "AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis" Journal of Cardiovascular Development and Disease 9, no. 11: 406.
https://doi.org/10.3390/jcdd9110406
APA Style
Lv, F., Jiang, Y., Wang, Y., Zhang, T., & Zhou, Y.
(2022). AGTR1rs5186 Polymorphism Is Associated with the Risk of Restenosis after Percutaneous Coronary Intervention: A Meta-Analysis. Journal of Cardiovascular Development and Disease, 9(11), 406.
https://doi.org/10.3390/jcdd9110406